Next RNS15 Sep 2021 09:25
Here's hoping that the next RNS is talking only about Zulu test results with the half year report to follow at the end of the month.
As mentioned elsewhere, I think the test result RNS (coupled with the increasing spodumene price) will give the market greater confidence in PREM and GR, and, therefore, we should see a much higher sp... with a higher sp, the cost of accelerating the DFS and extending to the EPO area will be much less.
GR needs to avoid anything that would be a drag on the sp, eg MNH and/or RHA and/or any other acquisition.
The next round of funding should then come in October, I hope, with more detailed info about the DFS plan and how the EPO area will be handled.
Things are shaping up very nicely - just need to get these test results out and we need GR to navigate a path that does no harm to the sp.